வெளிப்படுத்து உயிர் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெளிப்படுத்து உயிர் அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெளிப்படுத்து உயிர் அறிவியல் Today - Breaking & Trending Today

CellCarta Strengthens its Histological Biomarker Franchise by [...] | Comunicati stampa CataniaOggi


11 maggio 2021 14:35
Fonte: Adnkronos
#chimica-e-farmacia
- MONTREAL, May 11, 2021 /PRNewswire/ CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ( Reveal ), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta s position as a leading provider of histopathology biomarker services and will enable the company to broaden its offering in AI-enabled multi-omic data analysis services and applications.
Reveal Biosciences has created a new generation of Pathology Intelligence™ to enhance research, clinical trials, and improve patient outcomes globally.  Reveal s imageDx™ pathology platform combines cutting edge machine learning (ML)-AI with traditional histopathology to transform tissue biology into a ....

United States , Prnewswire Cellcarta , Claire Weston , Martin Leblanc , Guylaine Galipeau , Brian Schaffer Kristen Duarte , Marketing Communications , Life Sciences , Reveal Biosciences , San Diego California , Pathology Intelligence , About Reveal Biosciences , Media Contact , Prosek Partners , Brian Schaffer , Kristen Duarte , Global Marketing Director , ஒன்றுபட்டது மாநிலங்களில் , கிளாரி வெஸ்டன் , மார்டின் லெப்ளாங்க் , பிரையன் ஶேஃபர் கிறிஸ்டன் ட்வார்டே , சந்தைப்படுத்தல் தகவல்தொடர்புகள் , வாழ்க்கை அறிவியல் , வெளிப்படுத்து உயிர் அறிவியல் , சான் டியாகோ கலிஃபோர்னியா , மீடியா தொடர்பு ,

CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences


Reveal Biosciences Logo (CNW Group/CellCarta)
MONTREAL, May 11, 2021 /PRNewswire/ - CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ( Reveal ), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta s position as a leading provider of histopathology biomarker services and will enable the company to broaden its offering in AI-enabled multi-omic data analysis services and applications.
Reveal Biosciences has created a new generation of Pathology Intelligence™ to enhance research, clinical trials, and improve patient outcomes globally.  Reveal s imageDx™ pathology platform combines cutting edge machine learning (ML)-AI with traditional histopathology to transform tissue biology into actionable data.  Reve ....

United States , Claire Weston , Martin Leblanc , Life Sciences , Reveal Biosciences , San Diego California , Pathology Intelligence , ஒன்றுபட்டது மாநிலங்களில் , கிளாரி வெஸ்டன் , மார்டின் லெப்ளாங்க் , வாழ்க்கை அறிவியல் , வெளிப்படுத்து உயிர் அறிவியல் , சான் டியாகோ கலிஃபோர்னியா ,